Clinical Trial Update: Hyaluronidase Via LADD Scleroderma-induced Microstomia [EARLY_Phase 1]

View source ↗

Summary

Early-phase clinical trial investigating hyaluronidase delivered via LADD for microstomia in scleroderma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Microstomia
• Systemic Sclerosis

Drugs mentioned

• Hyaluronidase (hyaluronidase)

Snippet

Sponsor: University of Nebraska | Conditions: Microstomia, Scleroderma | EARLY_Phase 1 | Status: COMPLETED